Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD cover art

Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD

Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD

Listen for free

View show details

About this listen

Using biomarker testing and APOE genotyping to determine patient eligibility for amyloid-targeting therapies.

Credit available for this activity expires: 8/19/2026

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002844?ecd=bdc_podcast_libsyn_mscpedu

No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.